Original ArticleAdaptive servo-ventilation as treatment of persistent central sleep apnea in post-acute ischemic stroke patients

- Treatment of persistent central sleep apnea post ischemic stroke is evaluated.
- Adaptive servo ventilation suppresses central sleep apnea post ischemic stroke.
- Adaptive servo ventilation improves ESS in these patients.
- Adherence to therapy of these patients is good.

BackgroundAdaptive servo-ventilation (ASV) is a well-established treatment of central sleep apnea (CSA) related to congestive heart failure (CHF). Few studies have evaluated the effectiveness and adherence in patients with CSA of other etiologies, and even less is known about treatment of CSA in patients of post ischemic stroke.MethodsA single-centre retrospective analysis of ASV treatment for CSA in post-acute ischemic stroke patients without concomitant CHF was performed. Demographics, clinical data, sleep studies, ventilator settings, and adherence data were evaluated.ResultsOut of 154 patients on ASV, 15 patients had CSA related to ischemic stroke and were started on ASV a median of 11 months after the acute cerebrovascular event. Thirteen out of the 15 patients were initially treated with continuous positive airway pressure (11/15) and bilevel positive airway pressure (2/15) therapy with unsatisfactory control of CSA. ASV significantly improved AHI (46.7 ± 24.3 vs 8.5 ± 12/h, P = 0.001) and reduced ESS (8.7 ± 5.7 vs 5.6 ± 2.5, P = 0.08) with a mean nightly use of ASV of 5.4 ± 2.4 h at 3 months after the initiation of treatment. Results were maintained at 6 months.ConclusionASV was well tolerated and clinically effective in this group of patients with persistent CSA after ischemic stroke.